Long-term side effects are still unclear While GLP-1 drugs have been studied for diabetes for years, their long-term effects on weight loss and metabolism are still being researched
Conclusion 8
References Palmer SC, Tendal B, Mustafa RA et al (2021) Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials
This is different from dose reduction
Administration of NRF2 activator, which would be favorable for reinvigorating anti-tumor immunity and conferring the metabolic liabilities on cancer cells, in combination with inhibitors of glutamate and/or NEAA synthesis may be an effective anti-tumor therapy from the viewpoint of interaction between cancer cells and their microenvironment
After each week, the amount of Semaglutide in the body decreases gradually: After 1 week: About 50% remains After 2 weeks: Nearly 25% remains After 3 weeks: About 12.5% remains After 4 weeks: Roughly 6.25% remains After 5 weeks: Nearly 3.1% remains After 5 weeks, most of the medication is eliminated from the body, although very small traces may still remain up to 7 weeks